Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

Biogen Idec Products   
14 Cambridge Center
Cambridge,  MA  02142
United States
Telephone: (617) 679-2000
Fax: (617) 679-2617
URL: http://www.biogenidec.com
Email: info@biogenidec.com

Biogen Idec, based in Cambridge, Massachusetts, was formed with the 2003 merger of Biogen Incorporated and IDEC Pharmaceuticals Corporation. Biogen was founded in Switzerland in 1978. IDEC Pharmaceuticals was founded in San Francisco, California in 1985. Biogen Idec is a biotechnology company that distributes drug products in 70 countries. RITUXAN (R) is used to treat B-cell non-Hodgkin's lymphomas. AVONEX (R) and TYSABRI (R) treat patients with relapsing forms of multiple sclerosis. ZEVALIN (R) is a radioimmunotherapy that treats patients with relapsed or refractory, low-grade, follicular B-cell non-Hodgkin's lymphomas. In 2005, Biogen Idec formed an antibody development alliance with PDL BioPharma. In 2006, Biogen Idec acquired Conforma Therapeutics and Fumapharm AG. Biogen Idec maintains additional research centers and offices in North America, Europe, and Asia. The firm is listed on NASDAQ under the BIIB symbol.

Org. Type: Corporation Equity Type: Public
Company Status: Active Date Founded: 2003
Symbol: NASDAQ:BIIB

Products:
Biogen Idec--Company News

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.